Comprehensive coverage

The brain - serious diseases

Implanting a chip in the brain as recently done by Elon Musk's company Neurolink can, if done correctly, save patients with severe brain diseases, and that the patients no longer respond to drug treatment
Researchers are examining whether aerobic physical activity, which increases the level of oxytocin, the hormone of love and connection in the body, may improve the social functioning of those suffering from schizophrenia
Toxic proteins accumulate in the brains of Alzheimer's patients. In the familial Alzheimer's patients, the accumulation mechanism is clear since there is a circumstantial relationship between the mutations and the identity of the defective proteins. In the random disease, on the other hand, the reason for the accumulation of the defective proteins was unknown
On the spectrum of disorders caused by a defect in one gene
Researchers at the Walter and Eliza Hall Institute (WEHI) in Melbourne have solved a long-standing mystery regarding the role of a protein in removing damaged mitochondria from the body. These findings may pave the way for potential new treatments for Parkinson's disease
The molecule that carries with it a message of regeneration
Abnormal electrical activity in the brain triggers OCD and Parkinson's symptoms
The proteins and mechanisms required to fight the protein accumulations that lead to neurodegenerative diseases have been identified
The research team hopes that the tools developed in this study will pave the way for the development of similar treatments for other rare diseases
Professor Hermona Sorek, one of the world's leading researchers of gene expression in the brain, was able to find, in collaboration with her research colleagues, a molecular mechanism that occurs in the brains of Alzheimer's patients, which does not occur in men and which explains the acceleration of cognitive deterioration in Alzheimer's patients
The scientists of the institute have identified the cells in the brain that are responsible for the grace periods of the multiple sclerosis patients. The findings may pave the way for new treatments
The brain's control of subtle movements is based on complex mechanisms that challenge many researchers from different fields. Research conducted at the Technion sheds light on this issue and may lead to the development of innovative, personalized rehabilitation strategies
The research carried out at Ben Gurion University focused on the VDAC1 protein that controls mitochondrial activity and controls cell life and death
A seminal 2006 article in Nature claiming that beta-amyloid protein was the main cause of Alzheimer's was found to be partially fabricated. Long years of attempts to develop medicines were lost in vain * Twenty more articles by the same author are now being examined
An experimental drug developed in a laboratory may be suitable for the treatment of a variety of rare syndromes that impair brain function
AHDS patients are unable to walk or sit independently and do not even develop the ability to speak. So far, about 300 patients have been diagnosed in the world, however, due to being a rare syndrome that was recently identified, it can be estimated that the number of patients in the world is greater than this number.
At the Multidisciplinary Center for Brain Research at Bar-Ilan University, researchers investigate, among other things, the effect of age, brain injuries or neurological diseases such as Parkinson's disease on memory
Weizmann Institute of Science scientists have discovered a new pathway that may protect nerve cells in the brain and slow down the development of degenerative brain disease
Due to incorrect diagnosis and treatment: 4 in XNUMX children who have suffered a minor head injury may suffer from chronic post-concussion syndrome
Technion researchers have discovered proteins in our bodies that are able to prevent processes that cause neurodegenerative diseases
Researchers from Tel Aviv University identified for the first time the biological mechanism that causes the destruction of nerves in the muscular dystrophy disease ALS
A study from the Hebrew University published in the journal "Nature Communications" reveals the connection between a decrease in the frequency of beta waves and the disease and opens up the possibility of a more targeted and effective treatment for Parkinson's
A large-scale international study led by Tel Aviv University found that an experimental drug that received orphan drug status from the FDA for the future treatment of a rare developmental syndrome, may also cure a variety of symptoms related to autism, intellectual disability and Alzheimer's
Mutations causing S1R dysfunction are one of the causes of ALS (muscular dystrophy) and hereditary motor neuropathy. In another context, this receptor is a target site for the drug cocaine
Science website logo
Skip to content